Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer...
Xanthine oxidase inhibitors febuxostat and allopurinol are commonly used in the treatment of gout. Febuxostat inhibits the breast cancer resistance protein (BCRP) in vitro. Rosuvastatin is a BCRP...